1AE:ETR
argenx SE
811,80 €
arrow_downward
−0,47%(−3,80) 1 D
5. okt., 17:35:56 GMT+2 · EUR
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for 1AE …
Åpne
820,60 €
Høy
827,60 €
Lav
810,40 €
Markedsverdi
50,69 mrd.
Snittvolum
73,00
Volum
90,00
P/E-forhold
34,71
52 u høy
922,00 €
52 u lav
574,20 €
EPS
23,39 €
Antall ansatte
2k
Åpne
820,60 €
Høy
827,60 €
Lav
810,40 €
Markedsverdi
50,69 mrd.
Snittvolum
73,00
Volum
90,00
P/E-forhold
34,71
52 u høy
922,00 €
52 u lav
574,20 €
EPS
23,39 €
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 2 timer siden
argenx stock after-hours at EUR 810.80: minus 0.69 percent versus prior close
AD HOC NEWS
·
for 8 timer siden
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
Yahoo Finance
·
for 9 timer siden
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
AD HOC NEWS
·
for 1 døgn siden
argenx stock falls 1.79 percent as Goldman raises its target
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Om argenx SE